Homburger advised Santhera Pharmaceuticals Holding on the settlement of its first exchange offer for a convertible bond in Switzerland. Holders of current Santhera CHF 60 Unsecured Convertible Bonds due in 2022 have received new CHF 30,270,375 Senior Unsecured
Tags :Daniel Junginger
PolyPeptide Group AG, a global operator in peptide development and manufacturing, successfully priced its initial public offering (IPO) at CHF 64 per share, implying a market capitalization of CHF 2.12 bn. The base offering of the IPO
Homburger advised Credit Suisse (Switzerland) Ltd. and Investec Bank plc as mandated lead arrangers as well as the original lenders with regard to all legal aspects of the financing transaction. The team was led by
On January 29, 2021, MTH Retail Group Holding GmbH (MTH), OFFICE WORLD Holding AG (OWH), PEG Papeteristen Einkaufsgenossenschaft (PEG) and OFFIX Holding AG announced to combine their Swiss businesses in a new joint venture under the name
He worked at Nivalion for around 18 months, first as a case manager, then as an investment manager. He is a Swiss qualified attorney, Chartered Alternative Investment Analyst (CAIA) and holds a Master’s degree in
